These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27000662)

  • 1. Clonal origin and spread of metastatic prostate cancer.
    Van Etten JL; Dehm SM
    Endocr Relat Cancer; 2016 Apr; 23(4):R207-17. PubMed ID: 27000662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance.
    Liu A; Gao Y; Wang Q; Lin W; Ma Z; Yang X; Chen L; Xu D
    J Transl Med; 2023 Sep; 21(1):641. PubMed ID: 37726835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.
    Fan L; Fei X; Zhu Y; Pan J; Sha J; Chi C; Gong Y; Du X; Zhou L; Dong B; Xue W
    J Urol; 2021 Feb; 205(2):461-469. PubMed ID: 32897803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis.
    Yanagisawa T; Rajwa P; Kawada T; Mori K; Fukuokaya W; Petrov P; Quhal F; Laukhtina E; von Deimling M; Bianchi A; Majdoub M; Pradere B; Kramer G; Kimura T; Shariat SF
    J Urol; 2023 Sep; 210(3):416-429. PubMed ID: 37339479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells.
    Dago AE; Stepansky A; Carlsson A; Luttgen M; Kendall J; Baslan T; Kolatkar A; Wigler M; Bethel K; Gross ME; Hicks J; Kuhn P
    PLoS One; 2014; 9(8):e101777. PubMed ID: 25084170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolutionary history of lethal metastatic prostate cancer.
    Gundem G; Van Loo P; Kremeyer B; Alexandrov LB; Tubio JMC; Papaemmanuil E; Brewer DS; Kallio HML; Högnäs G; Annala M; Kivinummi K; Goody V; Latimer C; O'Meara S; Dawson KJ; Isaacs W; Emmert-Buck MR; Nykter M; Foster C; Kote-Jarai Z; Easton D; Whitaker HC; ; Neal DE; Cooper CS; Eeles RA; Visakorpi T; Campbell PJ; McDermott U; Wedge DC; Bova GS
    Nature; 2015 Apr; 520(7547):353-357. PubMed ID: 25830880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.
    Hahn AW; Stenehjem D; Nussenzveig R; Carroll E; Bailey E; Batten J; Maughan BL; Agarwal N
    Cancer Treat Res Commun; 2019; 19():100120. PubMed ID: 30743187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone Resistance and Neuroendocrine Differentiation Due to Accumulation of Genetic Lesions during Clonal Evolution of Prostate Cancer].
    Mikhaylenko DS; Efremov GD; Sivkov AV; Zaletaev DV
    Mol Biol (Mosk); 2016; 50(1):34-43. PubMed ID: 27028809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Evolution of Castration-resistant Prostate Cancer.
    Davies A; Conteduca V; Zoubeidi A; Beltran H
    Eur Urol Focus; 2019 Mar; 5(2):147-154. PubMed ID: 30772358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects.
    Frank S; Nelson P; Vasioukhin V
    F1000Res; 2018; 7():. PubMed ID: 30135717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.
    Erickson A; Hayes A; Rajakumar T; Verrill C; Bryant RJ; Hamdy FC; Wedge DC; Woodcock DJ; Mills IG; Lamb AD
    Eur Urol Oncol; 2021 Jun; 4(3):358-369. PubMed ID: 33888445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.
    Reimers MA; Yip SM; Zhang L; Cieslik M; Dhawan M; Montgomery B; Wyatt AW; Chi KN; Small EJ; Chinnaiyan AM; Alva AS; Feng FY; Chou J
    Eur Urol; 2020 Mar; 77(3):333-341. PubMed ID: 31640893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking the clonal origin of lethal prostate cancer.
    Haffner MC; Mosbruger T; Esopi DM; Fedor H; Heaphy CM; Walker DA; Adejola N; Gürel M; Hicks J; Meeker AK; Halushka MK; Simons JW; Isaacs WB; De Marzo AM; Nelson WG; Yegnasubramanian S
    J Clin Invest; 2013 Nov; 123(11):4918-22. PubMed ID: 24135135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
    Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
    Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.
    Crawford ED; Higano CS; Shore ND; Hussain M; Petrylak DP
    J Urol; 2015 Dec; 194(6):1537-47. PubMed ID: 26196735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Subtypes of Prostate Cancer.
    Arora K; Barbieri CE
    Curr Oncol Rep; 2018 Jun; 20(8):58. PubMed ID: 29858674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?
    Cahill EM; Pfail JL; Fu MZ; Saraiya B; Mayer T; Stephenson RD; Ennis RD; Hathout L; Deek MP; Ghodoussipour S; Jang TL
    Curr Urol Rep; 2023 Jul; 24(7):299-306. PubMed ID: 37017928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer.
    Wyatt AW; Azad AA; Volik SV; Annala M; Beja K; McConeghy B; Haegert A; Warner EW; Mo F; Brahmbhatt S; Shukin R; Le Bihan S; Gleave ME; Nykter M; Collins CC; Chi KN
    JAMA Oncol; 2016 Dec; 2(12):1598-1606. PubMed ID: 27148695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.